
Hyperthyroidism: treatment and medical options
Hyperthyroidism — the active hypersecretion of thyroid hormones by the thyroid gland — affects approximately 1-2% of the population, with

Endometriosis is a benign condition that affects between 5% and 10% of women of reproductive age. Among infertile women, its incidence is significantly higher, ranging between 25% and 40%. Although not a malignant disease, endometriosis has a profound impact on reproductive health and quality of life, being one of the leading causes of infertility.
Endometriosis is characterized by the presence of endometrial tissue outside the uterine cavity, which triggers inflammatory reactions and the formation of adhesions. These changes can affect the ovaries, fallopian tubes, and pelvic cavity, reducing the chances of natural conception. Women with endometriosis frequently experience chronic pelvic pain, severe dysmenorrhea, and infertility.
The link between endometriosis and decreased ovarian reserve is particularly significant. Adhesions and inflammation may compromise both oocyte quality and ovarian function, directly impacting fertility.
Anti-Müllerian hormone (AMH) is widely recognized as a biomarker of ovarian reserve and is commonly used in the assessment of female fertility. AMH levels provide valuable information about the number of remaining follicles in the ovaries and their potential response to ovarian stimulation.
One of the major advantages of AMH is its stability: levels show little variability across menstrual cycles, making it more reliable than other markers such as FSH or estradiol.
Studies show that women with endometriosis tend to have lower AMH levels compared to healthy women of the same age. This suggests that endometriosis directly affects ovarian reserve and may accelerate its decline. Ovarian endometriomas, in particular, have a significant impact on healthy ovarian tissue, reducing the number of viable follicles.
Furthermore, repeated surgical interventions to remove endometriotic cysts may lead to additional loss of ovarian tissue, further lowering AMH levels.
Assessing AMH levels in women with endometriosis is essential for determining infertility treatment strategies. Patients with low AMH may require assisted reproductive techniques such as in vitro fertilization (IVF).
Counseling is equally important, as endometriosis is a progressive disease and ovarian reserve may deteriorate quickly. Regular monitoring of AMH levels allows clinicians to make personalized decisions regarding the best timing for conception or the initiation of fertility treatment.
Endometriosis is a common condition that affects both fertility and ovarian reserve. AMH is a reliable and stable marker for evaluating ovarian function and plays a crucial role in managing women with endometriosis. Careful monitoring of AMH and early adoption of treatment strategies can significantly improve the chances of conception.

Hyperthyroidism — the active hypersecretion of thyroid hormones by the thyroid gland — affects approximately 1-2% of the population, with

You have recently received a diagnosis of low ovarian reserve and are unsure what it means for your chances of

Fertility clinic in Bucharest: endocrinology and assisted reproduction, in a single team If you are trying to conceive without success,

Vitamin D deficiency: symptoms if treated Unexplained fatigue, diffuse muscle pain, low mood, and frequent infections, these are signs that

Elevated Cortisol: Symptoms and What You Can Do Fatigue that persists even after sleep, excess weight concentrated on the abdomen,

The role of progesterone in in vitro fertilization What is progesterone and how is it produced? Progesterone in in vitro